Maruti, Honda, Mahindra and others stops manufacturing due to Covid19 outbreak

▴ Maruti Honda Mahindra and others stops manufacturing due to Covid19 outbreak
All automakers stops production til 31st March

Maruti Suzuki India (MSI), Mahindra & Mahindra and Honda Cars, recentlyannounced suspension of manufacturing activities across plants in the wake of the coronavirus outbreak in the country.

 MSI stopped production at its Gurgaon and Manesar plants with immediate effect, while Honda Cars India Ltd (HCIL) to end manufacturing at its two plants in the country till 31 March.

Meanwhile Mahindra & Mahindra (M&M) announced to suspend production at its manufacturing plants in Maharashtra.

Automaker Fiat also suspends  production in the country till the end of this month.

From other automobile companies,Hero MotoCorp and Honda Motorcycle and Scooter India (HMSI) suspended production across their manufacturing plants.

HMSI said, "The company will shut production and office operations at its facilities in Gurugram and Manesar (Haryana) with immediate effect till further notice."

The company's research and development centre at Rohtak will also remain closed, it added.

The duration of this shutdown will depend upon government policy, MSI said.

The company's two plants in Haryana—Manesar and Gurgaon—churn out 15.5 lakh vehicles per annum.

HCIL said production operations at  manufacturing plants in Greater Noida (Uttar Pradesh) and Tapukara (Rajasthan) will suspended from 23-31 March.

The company said its intention is to restart production on 1 April, however, this will be dependent upon advice from the government, health authorities, and market and supply conditions.

M&M said it has suspended manufacturing operations at its Nagpur plant with immediate effect and will also halt production at Chakan (Pune) and Kandivali (Mumbai) from Monday.

None of the company plants is working on Sunday also, M&M added.

"We are carefully monitoring the rapidly evolving COVID-19 pandemic and will continue to take swift and appropriate action on other plants in Maharashtra and across the nation," the company said.

Meanwhile, all company offices across the country have been ordered to work from home, it added.

Similarly, automaker Fiat Chrysler Automobiles (FCA) together with Fiat India Automobiles Private Limited (FIAPL), FCA's joint venture manufacturing facility in Ranjangaon, said the temporary suspension is in response to the increasing prevalence of positive COVID-19 cases in Maharashtra and particularly in Pune.

"There will be no retrenchment of any plant employees as a result of the plant closure and all will continue to receive their salaries during this closure period", the company said.

MG Motor India said production at its Halol (Gujarat) plant is closed till 25 March.

Market leader Hero MotoCorp said it has suspended production until 31 March.

"With the safety and well-being of its employees as top priority in view of the escalating COVID-19 situation, the company has decided to halt operations at all its global manufacturing facilities—including in India, Colombia and Bangladesh—and the Global Parts Centre (GPC) at Neemrana with immediate effect until 31 March, 2020," Hero MotoCorp said.

Employees at all the other functions and locations, including the Centre of Innovation and Technology (CIT) at Jaipur, will continue to work from home, except for those whose physical presence is necessary to run the day-to-day essential services, it added.

Similarly, Honda Motorcycle and Scooter India (HMSI) said it has suspended operations across its four manufacturing plants in the country with immediate effect.

"The well-being of employees and all stakeholders being the top priority, the company has temporarily announced shutdown of operations across all its four manufacturing plants with immediate effect till further notice," HMSI

Story Input :Firstpost

Tags : #Maruti #Honda #Mahinda #Fiat #Heromotocorp #Hmsi #MGmotor

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024